Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

HTGM

HTG Molecular Diagnostics (HTGM)

HTG Molecular Diagnostics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:HTGM
DataHoraFonteTítuloCódigoCompanhia
08/06/202317:52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HTGMHTG Molecular Diagnostics Inc
11/05/202307:03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HTGMHTG Molecular Diagnostics Inc
07/04/202317:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HTGMHTG Molecular Diagnostics Inc
13/02/202317:36Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:HTGMHTG Molecular Diagnostics Inc
10/02/202318:35Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:HTGMHTG Molecular Diagnostics Inc
03/02/202318:03Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:HTGMHTG Molecular Diagnostics Inc
22/12/202208:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:HTGMHTG Molecular Diagnostics Inc
22/12/202208:03Edgar (US Regulatory)Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex)NASDAQ:HTGMHTG Molecular Diagnostics Inc
21/12/202208:09Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:HTGMHTG Molecular Diagnostics Inc
07/12/202208:04Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:HTGMHTG Molecular Diagnostics Inc
06/12/202208:32Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:HTGMHTG Molecular Diagnostics Inc
17/11/202218:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:HTGMHTG Molecular Diagnostics Inc
11/11/202212:05TipRanksH.C. Wainwright Reaffirms Their Buy Rating on HTG Molecular Diagnostics (HTGM)NASDAQ:HTGMHTG Molecular Diagnostics Inc
31/10/202217:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:HTGMHTG Molecular Diagnostics Inc
21/10/202217:11Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:HTGMHTG Molecular Diagnostics Inc
15/08/202207:25TipRanksHTG Molecular Diagnostics (HTGM) Receives a Buy from H.C. WainwrightNASDAQ:HTGMHTG Molecular Diagnostics Inc
05/08/202207:09Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:HTGMHTG Molecular Diagnostics Inc
30/06/202207:25TipRanksAnalysts Offer Insights on Healthcare Companies: HTG Molecular Diagnostics (HTGM) and Galera Therapeutics (GRTX)NASDAQ:HTGMHTG Molecular Diagnostics Inc
08/04/202217:52Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:HTGMHTG Molecular Diagnostics Inc
07/04/202207:17TipRanksH.C. Wainwright Thinks HTG Molecular Diagnostics’ Stock is Going to RecoverNASDAQ:HTGMHTG Molecular Diagnostics Inc
25/03/202217:11Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:HTGMHTG Molecular Diagnostics Inc
11/01/202208:26TipRanksH.C. Wainwright Reiterates a Buy Rating on HTG Molecular Diagnostics (HTGM)NASDAQ:HTGMHTG Molecular Diagnostics Inc
10/12/202108:16TipRanksH.C. Wainwright Remains a Buy on HTG Molecular Diagnostics (HTGM)NASDAQ:HTGMHTG Molecular Diagnostics Inc
03/05/202117:03Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:HTGMHTG Molecular Diagnostics Inc
06/04/202110:06TipRanksHTG Molecular Drops Over 7% As 1Q Revenue Forecast Lags EstimatesNASDAQ:HTGMHTG Molecular Diagnostics Inc
25/03/202120:26Edgar (US Regulatory)Annual Report (10-k)NASDAQ:HTGMHTG Molecular Diagnostics Inc
15/01/202118:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:HTGMHTG Molecular Diagnostics Inc
27/03/202018:26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:HTGMHTG Molecular Diagnostics Inc
24/09/201917:05GlobeNewswire Inc.HTG Molecular Diagnostics Announces Completion of $22.5 Million Aggregate Financing, Consisting of $19.0 Million Public Offer...NASDAQ:HTGMHTG Molecular Diagnostics Inc
20/09/201910:28Business WireHTG Molecular Diagnostics Announces Pricing of $20.0 Million Aggregate Financing, Consisting of $16.6 Million Public Offering...NASDAQ:HTGMHTG Molecular Diagnostics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:HTGM